Brief: Oncorus Reports Third Quarter 2020 Financial Results And Provides Business Highlights

Oncorus

11/11/2020 12:24

Nov 11 (Reuters) - Oncorus Inc  ONCR.O :
    * ONCORUS REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND
PROVIDES BUSINESS HIGHLIGHTS
    * Q3 LOSS PER SHARE $21.73
    * EXPECTS TO HAVE SUFFICIENT CAPITAL TO FUND ITS OPERATING
EXPENSES AND CAPITAL EXPENDITURE REQUIREMENTS INTO 2023
    * CASH & CASH EQUIVALENTS WERE $54.0 MILLION AS OF SEPT 30,
2020,
EXCLUDING PROCEEDS FROM CO'S IPO IN OCTOBER 2020
    * PLANS TO NOMINATE ITS ONCR-GBM CLINICAL CANDIDATE IN
SECOND HALF
OF 2021
    * EXPECTS TO NOMINATE CLINICAL CANDIDATES FOR BOTH LEAD
SYNTHETIC,
IV ADMINISTERED VIRAL IMMUNOTHERAPY PROGRAMS IN H1 OF 2021

Source text for Eikon:  ID:nGNX8l6WJd 
Further company coverage:  ONCR.O 

 ((Reuters.Briefs@thomsonreuters.com;))